- Core team member and competitive intelligence lead for Takeda’s GI disease area strategy team; key contributor in strategy development including white space identification, market opportunity assessment, tumor mapping, and subsequent definition of strategic imperatives and critical success factors to enable pull through- As global R&D program team member, provide diverse competitive intelligence support including preclinical, translational, operational, clinical, and commercial… Show more - Core team member and competitive intelligence lead for Takeda’s GI disease area strategy team; key contributor in strategy development including white space identification, market opportunity assessment, tumor mapping, and subsequent definition of strategic imperatives and critical success factors to enable pull through- As global R&D program team member, provide diverse competitive intelligence support including preclinical, translational, operational, clinical, and commercial insights to Takeda’s immune cell engaged platform which comprises discovery, pre-IND, phase 1, and phase 2 programs- Partner with search & evaluation team to identify and evaluate key late stage opportunities for licensing / acquisition potential - Serve as competitive intelligence lead for GI franchise; core activities include diverse support for life cycle management strategy, monitoring of on market competitors to deliver timely and impactful insights to brand team and program development team, and evidence generation planning support Show less

- Executed over 20 successful engagements spanning due diligences, product valuation and go to market strategy, corporate strategy, R&D advisory, operations support, and market access strategy in rare disease, oncology, and cell & gene therapy- Experienced in secondary research, design and execution of primary research with KOLs, payers, and patient advocacy groups as well as revenue forecasting, indication / asset prioritization modeling, portfolio strategy, & workshop… Show more - Executed over 20 successful engagements spanning due diligences, product valuation and go to market strategy, corporate strategy, R&D advisory, operations support, and market access strategy in rare disease, oncology, and cell & gene therapy- Experienced in secondary research, design and execution of primary research with KOLs, payers, and patient advocacy groups as well as revenue forecasting, indication / asset prioritization modeling, portfolio strategy, & workshop planning- Directly communicated insights and recommendations to diverse audiences including executive / C-suite, commercial, and R&D leadership at top 20 pharma companies as well as biotech and patient advocacy groups Show less

- Developed model system to study dendritic cell dysfunction in systemic lupus erythematosus with BU’s Center for Regenerative Medicine- Leveraged CRSIPR/Cas9 gene editing and induced pluripotent stem cell modeling to define functional consequences of risk mutations in SLE

Teaching assistant for BU's Metropolitan College Fall 2015: ImmunologyFall 2016: Introduction to Biomedical ScienceSpring 2017: Biomedical Instrumentation and ImagingCourse Facilitator:Fall 2017: Medical Terminology ISpring 2018: Medical Terminology IIFall 2018: Medical Terminology I

Biochemistry tutor for Boston University Henry M. Goldman School of Dental Medicine

- Coordinated 4-5 projects resulting in 1 first author publication and 3 coauthor publications; 1 abstract selected for talk at international conference